SAVA Jan 2025 30.000 put
| Previous close | 17.70 |
| Open | 17.70 |
| Bid | 16.35 |
| Ask | 17.20 |
| Strike | 30.00 |
| Expiry date | 2025-01-17 |
| Day's range | 17.70 - 17.70 |
| Contract range | N/A |
| Volume | |
| Open interest | 87 |
Insider MonkeySilicon Motion Technology Corporation (SAVA): Evaluating Its Position Among Top Debt-Free Stocks
We recently compiled a list of the 7 Best Debt Free Stocks To Buy. In this article, we are going to take a look at where Cassava Sciences Inc (NASDAQ:SAVA) stands against the other debt free stocks. Debt has always been the fuel driving many companies in the equity markets. Access to cheap capital when […]
Simply Wall St.Cassava Sciences, Inc. (NASDAQ:SAVA): Is Breakeven Near?
With the business potentially at an important milestone, we thought we'd take a closer look at Cassava Sciences, Inc.'s...
GlobeNewswireCassava Sciences Reports Q2 2024 Financial Results and Operational Updates
$207.3 Million in Cash and Cash Equivalents at June 30, 2024.Company in Advanced Discussions to Resolve SEC Investigation. $40 Million Estimated Loss Contingency Recorded in Q2 for Resolution.Conference Webcast Scheduled for Today at 8:30AM ET. AUSTIN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on a novel treatment for Alzheimer’s disease, today reported financial results for the second quarter ended June 30, 2024. Net income w
